Heregulin antagonists and methods for their use
AssigneeGeorgetown University
InventorsDajun Yang, Shaomeng Wang, Alan P. Kozikowski, Marc E. Lippman
Life of this patent
Estimating the term…
Loading patent…
AssigneeGeorgetown University
InventorsDajun Yang, Shaomeng Wang, Alan P. Kozikowski, Marc E. Lippman
Estimating the term…
The invention provides a method of inhibiting cancer cell growth, and thereby of treating cancer comprising administering to a mammal afflicted with cancer an effective amount of the compound of formula (I), wherein the variables of R.sub.1, and R.sub.2 have the meanings defined in the specification. The present invention also provides novel compounds of formula (I) as well as novel pharmaceutical compositions and intermediates useful for preparing compounds of formula (I). The figure illustrates the structure and binding activity of compounds of the invention and some of the rifamycin analogs. ______________________________________ ##STR1## ______________________________________ Compounds R.sub.1 = ______________________________________ A1 --OH A2 --OH A3 --OH A4 --OH A5 --OH A6 --OH A7 --OH - A8 ##STR2## ______________________________________ Compounds R.sub.2 = ______________________________________ A1 #STR3## - A2 #STR4## - A3 #STR5## - A4 #STR6## - A5 #STR7## - A6 #STR8## - A7 #STR9## - A8 --H ______________________________________ Compounds IC.sub.50 (1) IC.sub.50 (2) ______________________________________ A1 10 uM 1 uM A2 10 uM 3 uM A3 10 uM 3 uM A4 50 uM 5 uM A5 >500 uM >50 uM A6 >500 uM >50 uM A7 >200 uM >50 uM A8 >500 M >50 uM ______________________________________
A therapeutic method to inhibit cancer cell growth comprising administering to a mammal (i.e. a human) in need of such therapy, an amount of a compound of formula (I):
A compound of formula (I) ##STR19## wherein R.sub.1 is OH or --CH.sub.2 C(O)N((C.sub.1 -C.sub.4)alkyl).sub.2 ;
Dependencies are inferred from the claim text.